BIOMAT Database Logo BIOMAT Database Logo

Biological activity of bacterial surface components: bacterial extracts and defined bacterial cell wall components as immunomodulators. 1990

W G Bessler, and B Kleine, and C Martinez Alonso, and L Biesert, and M Strecker, and K H Wiesmüller, and J Metzger, and G Jung
Institut für Immunbiologie der Universität, Freiburg, Federal Republic of Germany.

Bacterial extracts obtained from pathogenic strains occurring in lung infections (Broncho Vaxom) or urogenital infections (Urovaxom) as well as defined surface components of Gram-negative bacteria purified from bacteria or obtained by chemical synthesis were tested for their immunomodulatory properties in a murine system. The bacterial extracts were able to act as immunogens inducing an antigen-specific response. Both the bacterial extracts and the purified bacterial cell wall components constituted polyclonal activators of murine splenic B cells, as demonstrated by proliferation assays measuring the incorporation of [3H]thymidine into DNA. They were also able to act as immunoadjuvants increasing the SRBC and the BSA-TNP specific immune response, and could induce tumor cytotoxicity in bone marrow-derived macrophages. The results show that bacterial extracts and defined bacterial surface components constitute immunogens as well as immunomodulators in vitro and in vivo.

UI MeSH Term Description Entries
D008213 Lymphocyte Activation Morphologic alteration of small B LYMPHOCYTES or T LYMPHOCYTES in culture into large blast-like cells able to synthesize DNA and RNA and to divide mitotically. It is induced by INTERLEUKINS; MITOGENS such as PHYTOHEMAGGLUTININS, and by specific ANTIGENS. It may also occur in vivo as in GRAFT REJECTION. Blast Transformation,Blastogenesis,Lymphoblast Transformation,Lymphocyte Stimulation,Lymphocyte Transformation,Transformation, Blast,Transformation, Lymphoblast,Transformation, Lymphocyte,Activation, Lymphocyte,Stimulation, Lymphocyte
D008262 Macrophage Activation The process of altering the morphology and functional activity of macrophages so that they become avidly phagocytic. It is initiated by lymphokines, such as the macrophage activation factor (MAF) and the macrophage migration-inhibitory factor (MMIF), immune complexes, C3b, and various peptides, polysaccharides, and immunologic adjuvants. Activation, Macrophage,Activations, Macrophage,Macrophage Activations
D008807 Mice, Inbred BALB C An inbred strain of mouse that is widely used in IMMUNOLOGY studies and cancer research. BALB C Mice, Inbred,BALB C Mouse, Inbred,Inbred BALB C Mice,Inbred BALB C Mouse,Mice, BALB C,Mouse, BALB C,Mouse, Inbred BALB C,BALB C Mice,BALB C Mouse
D010455 Peptides Members of the class of compounds composed of AMINO ACIDS joined together by peptide bonds between adjacent amino acids into linear, branched or cyclical structures. OLIGOPEPTIDES are composed of approximately 2-12 amino acids. Polypeptides are composed of approximately 13 or more amino acids. PROTEINS are considered to be larger versions of peptides that can form into complex structures such as ENZYMES and RECEPTORS. Peptide,Polypeptide,Polypeptides
D003602 Cytotoxicity, Immunologic The phenomenon of target cell destruction by immunologically active effector cells. It may be brought about directly by sensitized T-lymphocytes or by lymphoid or myeloid "killer" cells, or it may be mediated by cytotoxic antibody, cytotoxic factor released by lymphoid cells, or complement. Tumoricidal Activity, Immunologic,Immunologic Cytotoxicity,Immunologic Tumoricidal Activities,Immunologic Tumoricidal Activity,Tumoricidal Activities, Immunologic
D006090 Gram-Negative Bacteria Bacteria which lose crystal violet stain but are stained pink when treated by Gram's method. Gram Negative Bacteria
D000276 Adjuvants, Immunologic Substances that augment, stimulate, activate, potentiate, or modulate the immune response at either the cellular or humoral level. The classical agents (Freund's adjuvant, BCG, Corynebacterium parvum, et al.) contain bacterial antigens. Some are endogenous (e.g., histamine, interferon, transfer factor, tuftsin, interleukin-1). Their mode of action is either non-specific, resulting in increased immune responsiveness to a wide variety of antigens, or antigen-specific, i.e., affecting a restricted type of immune response to a narrow group of antigens. The therapeutic efficacy of many biological response modifiers is related to their antigen-specific immunoadjuvanticity. Immunoactivators,Immunoadjuvant,Immunoadjuvants,Immunologic Adjuvant,Immunopotentiator,Immunopotentiators,Immunostimulant,Immunostimulants,Adjuvant, Immunologic,Adjuvants, Immunological,Immunologic Adjuvants,Immunological Adjuvant,Adjuvant, Immunological,Immunological Adjuvants
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000942 Antigens, Bacterial Substances elaborated by bacteria that have antigenic activity. Bacterial Antigen,Bacterial Antigens,Antigen, Bacterial
D001402 B-Lymphocytes Lymphoid cells concerned with humoral immunity. They are short-lived cells resembling bursa-derived lymphocytes of birds in their production of immunoglobulin upon appropriate stimulation. B-Cells, Lymphocyte,B-Lymphocyte,Bursa-Dependent Lymphocytes,B Cells, Lymphocyte,B Lymphocyte,B Lymphocytes,B-Cell, Lymphocyte,Bursa Dependent Lymphocytes,Bursa-Dependent Lymphocyte,Lymphocyte B-Cell,Lymphocyte B-Cells,Lymphocyte, Bursa-Dependent,Lymphocytes, Bursa-Dependent

Related Publications

W G Bessler, and B Kleine, and C Martinez Alonso, and L Biesert, and M Strecker, and K H Wiesmüller, and J Metzger, and G Jung
Bacterial cell wall components as immunomodulators--I. Lipopeptides as adjuvants for parenteral and oral immunization.
January 1997, International journal of immunopharmacology,
W G Bessler, and B Kleine, and C Martinez Alonso, and L Biesert, and M Strecker, and K H Wiesmüller, and J Metzger, and G Jung
Bacterial cell wall components as immunomodulators--II. The bacterial cell wall extract OM-85 BV as unspecific activator, immunogen and adjuvant in mice.
January 1997, International journal of immunopharmacology,
W G Bessler, and B Kleine, and C Martinez Alonso, and L Biesert, and M Strecker, and K H Wiesmüller, and J Metzger, and G Jung
Biological activity of bacterial cell wall components. Immunogenicity of an immunostimulating bacterial extract.
April 1993, Arzneimittel-Forschung,
W G Bessler, and B Kleine, and C Martinez Alonso, and L Biesert, and M Strecker, and K H Wiesmüller, and J Metzger, and G Jung
Biological activity of bacterial cell-wall components: immunogenicity of the bacterial extract OM-89.
February 1995, Immunopharmacology,
W G Bessler, and B Kleine, and C Martinez Alonso, and L Biesert, and M Strecker, and K H Wiesmüller, and J Metzger, and G Jung
The presence in faecal extracts of bacterial cell wall components resembling viral structures.
August 1978, Acta pathologica et microbiologica Scandinavica. Section B, Microbiology,
W G Bessler, and B Kleine, and C Martinez Alonso, and L Biesert, and M Strecker, and K H Wiesmüller, and J Metzger, and G Jung
Biological activity of bacterial surface components. Immunogenicity and immunomodulatory properties of a bacterial extract from Escherichia coli.
March 1991, Arzneimittel-Forschung,
W G Bessler, and B Kleine, and C Martinez Alonso, and L Biesert, and M Strecker, and K H Wiesmüller, and J Metzger, and G Jung
Bacterial toxins as immunomodulators.
January 2009, Advances in experimental medicine and biology,
W G Bessler, and B Kleine, and C Martinez Alonso, and L Biesert, and M Strecker, and K H Wiesmüller, and J Metzger, and G Jung
Components of gut bacteria as immunomodulators.
May 1998, International journal of food microbiology,
W G Bessler, and B Kleine, and C Martinez Alonso, and L Biesert, and M Strecker, and K H Wiesmüller, and J Metzger, and G Jung
Biological activities solubilized cell surface components.
January 1974, Advances in experimental medicine and biology,
W G Bessler, and B Kleine, and C Martinez Alonso, and L Biesert, and M Strecker, and K H Wiesmüller, and J Metzger, and G Jung
Cell wall substrate specificity of six different lysozymes and lysozyme inhibitory activity of bacterial extracts.
June 2006, FEMS microbiology letters,
Copied contents to your clipboard!